Last edition
News about "The European Commission has granted Orphan Medicin"
The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818
Medivir today announced that the European Commission, in accordance with the opinion from the European Medicines Agency (EMA), has granted orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer
The European Commission Has Granted Orphan Medicin | 05/07/2020 | By Darshana | 402
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy